Skip to main content

Table 2 Associations between dietary sodium, potassium, and sodium to potassium ratio (2008-2011) with incident chronic kidney diseasea (2014–2017), Hispanic Community Health Study/Study of Latinos

From: Associations of sodium and potassium intake with chronic kidney disease in a prospective cohort study: findings from the Hispanic Community Health Study/Study of Latinos, 2008–2017

 

Model 1

Model 2

Model 3

Model 4

 

Incidence Density Ratio

(95% CI)

Incidence Density Ratio

(95% CI)

Incidence Density Ratio

(95% CI)

Incidence Density Ratio

(95% CI)

Sodium (500 mg increment)

1.00 (0.97, 1.04)

1.01 (0.97, 1.05)

1.01 (0.96, 1.07)

1.05 (0.99, 1.12)

Potassium (500 mg decrement)

1.05 (1.00, 1.10)

1.04 (1.00, 1.09)

1.08 (0.99, 1.17)

1.11 (1.00, 1.24)

Sodium: Potassium (molar ratio)

1.12 (1.00, 1.24)

1.11 (1.00, 1.22)

1.23 (1.05, 1.44)

1.21 (1.04, 1.42)

  1. aIncident chronic kidney disease is defined as eGFR < 60 ml/min/1.73 m2 with > 1 ml/min/1.73 m2 decline and/or albumin to creatinine ratio ≥ 30 mg/g. Model 1 is adjusted for: age, sex, time between visits, and Hispanic/Latino heritage group, with the potassium model adjusted for sodium intake and the sodium model is adjusted for potassium intake; Model 2 is additionally adjusted for: education, income, marital status, nativity/years in the US, study site, and health insurance; Model 3 is additionally adjusted for: smoking, drinking, and physical activity; Model 4 is additionally adjusted for: body mass index, systolic blood pressure, hypertension medication, total cholesterol, and diabetes